Abzena and BioXpress Collaborate to Develop and Manufacture Biosimilars for Third Party Customers
Shots:
- The alliance creates an integrated solution between the companies with expertise in biosimilar development and GMP manufacture
- The collaboration will benefit biosimilar drug developers with the design consultancy- cell line and process development through to clinical and commercial GMP manufacture
- The partnership provides a flexible & innovative approach from small scale biosimilar development through to large scale manufacturing
| Ref: Abzena | Image: Business Wire
Click here to read the full press release
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com